Clinical trials: Locally Recurrent Lung Non-Small Cell Carcinoma

Lung Cancer

Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

• Completed
• Age: 18 to 120 years
• Phase 1/2
• Results posted

RATIONALE: Nelfinavir may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radiation therapy uses high energy x-rays to kill tumor cells.

Trial name

NCT00589056

Testing

cisplatin, etoposide, nelfinavir mesylate

Where

United States

Volunteers

55 people

Sponsor

Abramson Cancer Center at Penn Medicine